Tendencias Ahora
Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.
¿Ya eres miembro? Iniciar sesión
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class ant... Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. Mostrar más
Período † | Variación(Ptos) | Variación % | Apertura | Precio Máximo | Precio Mínimo | Avg. Vol. diario | Precio Promedio Ponderado | |
---|---|---|---|---|---|---|---|---|
1 | -0.3181 | -31.81 | 1 | 1.03 | 0.671 | 407456 | 0.87014407 | CS |
4 | -0.2881 | -29.7010309278 | 0.97 | 1.03 | 0.671 | 305874 | 0.87859103 | CS |
12 | -0.3042 | -30.8487982963 | 0.9861 | 1.33 | 0.671 | 476475 | 0.99269241 | CS |
26 | -0.4981 | -42.2118644068 | 1.18 | 1.41 | 0.671 | 351124 | 1.04923855 | CS |
52 | -3.0021 | -81.490228013 | 3.684 | 21.6 | 0.671 | 18271803 | 9.14253061 | CS |
156 | -2114.3181 | -99.9677588652 | 2115 | 3667.5 | 0.671 | 9344245 | 196.18044159 | CS |
260 | -2915.3181 | -99.9766152263 | 2916 | 20113.2 | 0.671 | 10676420 | 3713.03302594 | CS |
Parece que no se ha autenticado. Haga click al botón de abajo para iniciar la sesión y ver los símbolos recientemente consultados.
Soporte: (55) 4170 8128 | soporte@advfn.mx
Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones